Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98

FDA recall notice · announced November 20, 2024 · Cipla

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98

Reason for recall

Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.

Notes

Distribution: USA nationwide.
Lot/code information: Lot # NB240316, Exp 12/31/25
Quantity: 1,875 boxes (cipla and exlan)
Status: Ongoing
Products in this recall event:
- Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76282-0478-90 (D-0044-2025)
- Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98 (D-0043-2025)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.